Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
…, N Kouphou, RP Galao, G Betancor, HD Wilson… - Nature …, 2020 - nature.com
Antibody responses to SARS-CoV-2 can be detected in most infected individuals 10–15 d
after the onset of COVID-19 symptoms. However, due to the recent emergence of SARS-CoV-…
after the onset of COVID-19 symptoms. However, due to the recent emergence of SARS-CoV-…
[PDF][PDF] Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity
…, J Debebe, F Coll, AW Signell, G Betancor, HD Wilson… - Cell, 2021 - cell.com
Global dispersal and increasing frequency of the SARS-CoV-2 spike protein variant D614G
are suggestive of a selective advantage but may also be due to a random founder effect. We …
are suggestive of a selective advantage but may also be due to a random founder effect. We …
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study
…, F Coll, AW Signell, G Betancor, HD Wilson… - The Lancet Public …, 2021 - thelancet.com
Background The SARS-CoV-2 variant B.1.1.7 was first identified in December, 2020, in
England. We aimed to investigate whether increases in the proportion of infections with this …
England. We aimed to investigate whether increases in the proportion of infections with this …
Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community …
…, RP Galão, B Merrick, AW Signell, HD Wilson… - PLoS …, 2020 - journals.plos.org
There is a clear requirement for an accurate SARS-CoV-2 antibody test, both as a complement
to existing diagnostic capabilities and for determining community seroprevalence. We …
to existing diagnostic capabilities and for determining community seroprevalence. We …
The P681H mutation in the spike glycoprotein of the alpha variant of SARS-CoV-2 escapes IFITM restriction and is necessary for type I interferon resistance
MJ Lista, H Winstone, HD Wilson, A Dyer… - Journal of …, 2022 - Am Soc Microbiol
The appearance of new dominant variants of concern (VOC) of severe acute respiratory
syndrome coronavirus type 2 (SARS-CoV-2) threatens the global response to the coronavirus …
syndrome coronavirus type 2 (SARS-CoV-2) threatens the global response to the coronavirus …
[HTML][HTML] Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 infection early in the pandemic and the role of unidentified cases in …
…, T Charalampous, AW Signell, HD Wilson… - Clinical Microbiology …, 2022 - Elsevier
Objectives To analyse nosocomial transmission in the early stages of the coronavirus 2019 (COVID-19)
pandemic at a large multisite healthcare institution. Nosocomial incidence is …
pandemic at a large multisite healthcare institution. Nosocomial incidence is …
Real-world evaluation of a novel technology for quantitative simultaneous antibody detection against multiple SARS-CoV-2 antigens in a cohort of patients presenting …
…, TKI Mark, AW Signell, G Betancor, HD Wilson… - Analyst, 2020 - pubs.rsc.org
An evaluation of a rapid portable gold-nanotechnology measuring SARS-CoV-2 IgM, IgA
and IgG antibody concentrations against spike 1 (S1), spike 2 (S) and nucleocapsid (N) was …
and IgG antibody concentrations against spike 1 (S1), spike 2 (S) and nucleocapsid (N) was …
The P681H mutation in the Spike glycoprotein confers Type I interferon resistance in the SARS-CoV-2 alpha (B. 1.1. 7) variant
MJ Lista, H Winstone, HD Wilson, A Dyer, S Pickering… - BioRxiv, 2021 - biorxiv.org
Variants of concern (VOCs) of severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-2)
threaten the global response to the COVID-19 pandemic. The alpha (B.1.1.7) variant …
threaten the global response to the COVID-19 pandemic. The alpha (B.1.1.7) variant …
Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes …
…, R Pedro Galão, S Pickering, A Botgros, HD Wilson… - PLoS …, 2021 - journals.plos.org
During the first wave of the global COVID-19 pandemic the clinical utility and indications for
SARS-CoV-2 serological testing were not clearly defined. The urgency to deploy serological …
SARS-CoV-2 serological testing were not clearly defined. The urgency to deploy serological …
Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 transmission identifies community social distancing as the dominant intervention …
…, T Charalampous, AW Signell, HD Wilson… - medRxiv, 2020 - medrxiv.org
Many healthcare facilities report SARS-CoV-2 outbreaks but transmission analysis is complicated
by the high prevalence of infection and limited viral genetic diversity. The contribution …
by the high prevalence of infection and limited viral genetic diversity. The contribution …
